化合物PKI 14-22 amide, myristoylated Acetate T21983L

Product Introduction
Bioactivity


英文名: PKI 14-22 amide, myristoylated Acetate

描述: PKI 14-22 amide, myristoylated Acetate 抑制 cAMP 依赖性蛋白激酶 (PKA) 并阻断脊髓给药 8-溴-cAMP 产生的痛觉过敏。

体外活性: ?Myristoylated PKI 14-22 amide reduced the IgG-mediated phagocytic response in a manner of dose-dependent.?When the concentration is higher than 10 μM, PKI 14-22 amide can inhibit neutrophil adhesion, which make the phagocytosis measurements impossible to perform

存储条件: keep away from moisturePowder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 55 mg/ml (43.32 mM)


关键字: PKI 1422 amide, myristoylated Acetate | PKI 14 22 amide, myristoylated Acetate | PKI 14-22 amide, myristoylated Acetate

相关产品: PKI (5-24) Acetate(99534-03-9 free base) | Capivasertib | Daphnetin | R547 | PKA-IN-1 | CREBtide acetate(149155-45-3 free base) | MLN8054 | Malantide acetate(86555-35-3 free base) | Rottlerin | NH125

相关库: Kinase Inhibitor Library | Peptide Compound Library | Anti-Obesity Compound Library | Tyrosine Kinase Inhibitor Library | NO PAINS Compound Library

化合物PKI 14-22 amide, myristoylated Acetate T21983L信息由TargetMol中国为您提供，如您想了解更多关于化合物PKI 14-22 amide, myristoylated Acetate T21983L报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途